BNP Paribas Financial Markets’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.43M | Sell |
579,430
-11,847
| -2% | -$151K | ﹤0.01% | 1743 |
|
|
2025
Q4 | $5.32M | Buy |
591,277
+541,026
| +1,077% | +$7.45M | ﹤0.01% | 2007 |
|
|
2025
Q3 | $868K | Sell |
50,251
-376,416
| -88% | -$4.64M | ﹤0.01% | 3216 |
|
|
2025
Q2 | $4M | Buy |
426,667
+86,210
| +25% | +$708K | ﹤0.01% | 2006 |
|
|
2025
Q1 | $2.42M | Sell |
340,457
-98,001
| -22% | -$990K | ﹤0.01% | 2242 |
|
|
2024
Q4 | $5.11M | Buy |
438,458
+192,096
| +78% | +$3M | ﹤0.01% | 1761 |
|
|
2024
Q3 | $5.06M | Buy |
246,362
+115,351
| +88% | +$2.66M | ﹤0.01% | 1496 |
|
|
2024
Q2 | $2.93M | Buy |
131,011
+56,496
| +76% | +$1.35M | ﹤0.01% | 1693 |
|
|
2024
Q1 | $2.05M | Sell |
74,515
-135,646
| -65% | -$3.77M | ﹤0.01% | 2043 |
|
|
2023
Q4 | $6.41M | Buy |
210,161
+1,930
| +0.9% | +$55.5K | 0.01% | 1265 |
|
|
2023
Q3 | $6.58M | Buy |
208,231
+13,023
| +7% | +$505K | 0.01% | 1096 |
|
|
2023
Q2 | $7.96M | Buy |
195,208
+497
| +0.3% | +$20.2K | 0.02% | 1011 |
|
|
2023
Q1 | $7.26M | Buy |
194,711
+113,839
| +141% | +$4.46M | 0.02% | 1054 |
|
|
2022
Q4 | $2.82M | Sell |
80,872
-33,459
| -29% | -$1.59M | 0.01% | 1581 |
|
|
2022
Q3 | $6.4M | Buy |
114,331
+64,651
| +130% | +$4.01M | 0.02% | 1235 |
|
|
2022
Q2 | $2.57M | Sell |
49,680
-10,261
| -17% | -$521K | 0.01% | 1605 |
|
|
2022
Q1 | $4.36M | Buy |
59,941
+22,983
| +62% | +$1.95M | 0.01% | 1377 |
|
|
2021
Q4 | $4.37M | Buy |
36,958
+23,187
| +168% | +$2.9M | 0.01% | 1441 |
|
|
2021
Q3 | $1.85M | Buy |
13,771
+11,341
| +467% | +$1.72M | ﹤0.01% | 1956 |
|
|
2021
Q2 | $393K | Sell |
2,430
-6,034
| -71% | -$470K | ﹤0.01% | 2644 |
|
|
2021
Q1 | $679K | Buy |
8,464
+1,678
| +25% | +$113K | ﹤0.01% | 2386 |
|
|
2020
Q4 | $369K | Sell |
6,786
-4,993
| -42% | -$181K | ﹤0.01% | 2607 |
|
|
2020
Q3 | $234K | Buy |
11,779
+5,566
| +90% | +$116K | ﹤0.01% | 2684 |
|
|
2020
Q2 | $131K | Sell |
6,213
-14,663
| -70% | -$249K | ﹤0.01% | 2662 |
|
|
2020
Q1 | $255K | Buy |
20,876
+15,532
| +291% | +$209K | ﹤0.01% | 2735 |
|
|
2019
Q4 | $78.4K | Sell |
5,344
-892
| -14% | -$12.4K | ﹤0.01% | 3405 |
|
|
2019
Q3 | $83.3K | Buy |
6,236
+1,726
| +38% | +$27.5K | ﹤0.01% | 3210 |
|
|
2019
Q2 | $73.8K | Sell |
4,510
-3,138
| -41% | -$49.3K | ﹤0.01% | 3204 |
|
|
2019
Q1 | $131K | Buy |
7,648
+6,914
| +942% | +$103K | ﹤0.01% | 2961 |
|
|
2018
Q4 | $10K | Sell |
734
-3,759
| -84% | -$69.9K | ﹤0.01% | 3350 |
|
|
2018
Q3 | $129K | Sell |
4,493
-3,317
| -42% | -$96.5K | ﹤0.01% | 2615 |
|
|
2018
Q2 | $214K | Buy |
7,810
+4,479
| +134% | +$109K | ﹤0.01% | 2408 |
|
|
2018
Q1 | $70.3K | Sell |
3,331
-555
| -14% | -$13.6K | ﹤0.01% | 3373 |
|
|
2017
Q4 | $74.7K | Buy |
3,886
+2,414
| +164% | +$55.7K | ﹤0.01% | 3458 |
|
|
2017
Q3 | $36.6K | Sell |
1,472
-23
| -2% | -$433 | ﹤0.01% | 3307 |
|
|
2017
Q2 | $23.9K | Buy |
1,495
+1,300
| +667% | +$18.2K | ﹤0.01% | 3563 |
|
|
2017
Q1 | $2.75K | Sell |
195
-313
| -62% | -$4.2K | ﹤0.01% | 3448 |
|
|
2016
Q4 | $6.66K | Sell |
508
-50
| -9% | -$751 | ﹤0.01% | 3614 |
|
|
2016
Q3 | $9.5K | Buy |
558
+282
| +102% | +$5.46K | ﹤0.01% | 3185 |
|
|
2016
Q2 | $5.89K | Buy |
+276
| New | +$7.34K | ﹤0.01% | 3191 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
